Home > Insider Trading > Questcor Pharmaceuticals Inc

Questcor Pharmaceuticals Inc (QCOR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
21 - 30
Next >>

ACADIA Pharmaceuticals Inc. (ACAD), Rite Aid Corporation (RAD), Questcor Pharmaceuticals Inc (QCOR): Are Any Of These Top Performers A Sell?

I began using Motley Fool’s CAPS as a way to disclose when I purchased and sold stocks, and my 97.2 rating showcases my last 10 months.

Keep Reading →

August 2nd, 2013 - News

Greenbrier Companies Inc (GBX), NextEra Energy, Inc. (NEE), Citigroup Inc. (C): Roundtable: 1 Stock to Buy in August

Dan Caplinger: My stock for the month is Greenbrier Companies Inc (NYSE:GBX), a small company that focuses on sellingand leasing various types of railcars for the railroad industry.

Keep Reading →

August 2nd, 2013 - News

Questcor Pharmaceuticals Inc (QCOR), Sarepta Therapeutics Inc (SRPT): Here’s What This $7 Billion Contrarian Has Been Buying

Today, let's look at Tocqueville Asset Management, a portfolio manager with a contrarian bent, believing that "the best investment results over time are achieved outside the mainstream consensus," and...

Keep Reading →

August 2nd, 2013 - Hedge Funds

Things You Need to Know From Questcor Pharmaceuticals Inc (QCOR)'s Killer Q2 Earnings

Three months ago after Questcor Pharmaceuticals Inc (NASDAQ:QCOR) announced its first-quarter financial results, I asked if those results were as bad as they looked.

Keep Reading →

July 31st, 2013 - News

Facebook Inc (FB), Baidu.com, Inc. (ADR) (BIDU) & Last Week's Biggest Winners

Let's start with Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), which soared after Google Inc (NASDAQ:GOOG) moved to take a small stake in the Taiwanese chipmaker's majority-owned display subsidiary.

Keep Reading →

July 29th, 2013 - News

Questcor Pharmaceuticals Inc (QCOR), Biogen Idec Inc (BIIB): A Biotech Betting Everything on a Single Drug

One was the sales growth of Acthar Gel and the addition of BioVectra sales during Q1 2013. The other was the announcement of acquiring exclusive rights of Synacthen from Novartis AG (ADR) (NYSE:NVS).

Keep Reading →

July 28th, 2013 - News

Medivation Inc (MDVN), Questcor Pharmaceuticals Inc (QCOR): The Best Performing Biotech Stocks of the Last Decade

Biotech is booming these days. But that's not a new story by any means. Biotech stocks as a group have done very well over the past several years.

Keep Reading →

July 24th, 2013 - News

Celgene Corporation (CELG): Does This BiotechStudy Matter to You?

Celgene Corporation (NASDAQ:CELG) fell 2.6% on Thursday after disappointing clinical data for its blood cancer drug Revlimid.

Keep Reading →

July 23rd, 2013 - News

Celgene Corporation (CELG): Does This BiotechStudy Matter to You?

Celgene Corporation (NASDAQ:CELG) fell 2.6% on Thursday after disappointing clinical data for its blood cancer drug Revlimid.

Keep Reading →

July 22nd, 2013 - News

Questcor Pharmaceuticals Inc (QCOR): Close To New Highs, Should You Like This Biotech?

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) has a particularly fascinating history, having been at the center of controversy for the better part of its existence. For several years, investors have enjoyed...

Keep Reading →

July 17th, 2013 - News